{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T05:11:55Z","timestamp":1721970715739},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.leukres.2007.09.018","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T12:20:25Z","timestamp":1194351625000},"page":"811-819","source":"Crossref","is-referenced-by-count":7,"title":["Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines"],"prefix":"10.1016","volume":"32","author":[{"given":"Megan","family":"Dillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Minear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Lannutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.09.018_bib1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.09.018_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/asheducation-2003.1.200","article-title":"Chronic myeloproliferative disorders","author":"Spivak","year":"2003","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.leukres.2007.09.018_bib3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib4","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood-2002-03-0949","article-title":"Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera","volume":"100","author":"Klippel","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib5","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2002.11.507","article-title":"Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia","volume":"20","author":"Teofili","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2007.09.018_bib6","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2003-03-0919","article-title":"Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis","volume":"102","author":"Klippel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1719635","article-title":"GPI-anchored cell-surface molecules complexed to protein tyrosine kinases","volume":"254","author":"Stefanova","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.leukres.2007.09.018_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-2478(98)00054-6","article-title":"Signal transduction in leucocytes via GPI-anchored proteins: an experimental artefact or an aspect of immunoreceptor function?","volume":"63","author":"Horejsi","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.leukres.2007.09.018_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1074\/jbc.273.1.315","article-title":"The Jak\/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells","volume":"273","author":"Dumler","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.09.018_bib10","doi-asserted-by":"crossref","first-page":"28563","DOI":"10.1074\/jbc.272.45.28563","article-title":"Urokinase receptor is associated with the components of the JAK1\/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598","volume":"272","author":"Koshelnick","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.09.018_bib11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.181.4.1381","article-title":"Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes","volume":"181","author":"Bohuslav","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2007.09.018_bib12","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/emboj\/18.11.3013","article-title":"Urokinase receptor-dependent and -independent p56\/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence","volume":"18","author":"Chiaradonna","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2007.09.018_bib13","first-page":"1","article-title":"Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis","volume":"25","author":"Eaton","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2007.09.018_bib14","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V87.6.2162.bloodjournal8762162","article-title":"Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl","volume":"87","author":"Alexander","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib15","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1038\/sj.onc.1205323","article-title":"The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production","volume":"21","author":"Kaushansky","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.09.018_bib16","doi-asserted-by":"crossref","first-page":"P5640","DOI":"10.1073\/pnas.89.12.5640","article-title":"Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily","volume":"89","author":"Vigon","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.018_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V94.1.365.413a46_365_367","article-title":"Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding","volume":"94","author":"Sabath","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cytogfr.2006.09.005","article-title":"Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders","volume":"17","author":"Kaushansky","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.leukres.2007.09.018_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1749-6632.2001.tb03599.x","article-title":"Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias","volume":"938","author":"Germeshausen","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.leukres.2007.09.018_bib20","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1182\/blood-2003-10-3471","article-title":"Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin","volume":"103","author":"Ding","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib21","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib22","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.leukres.2007.09.018_bib23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2007.09.018_bib24","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.09.018_bib25","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2007.09.018_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2007.09.018_bib27","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.09.018_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2404206","article-title":"JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained","volume":"20","author":"Steensma","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.09.018_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hon.761","article-title":"The V617F JAK2 mutation and the myeloproliferative disorders","volume":"23","author":"Percy","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.leukres.2007.09.018_bib30","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2006-04-017392","article-title":"Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera","volume":"108","author":"Ishii","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.exphem.2006.12.007","article-title":"In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele","volume":"35","author":"Gaikwad","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2007.09.018_bib32","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2005-04-1515","article-title":"The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients","volume":"106","author":"Goerttler","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib33","first-page":"405","article-title":"Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation","volume":"90","author":"Mnjoyan","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.09.018_bib34","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1073\/pnas.94.6.2350","article-title":"Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain","volume":"94","author":"Drachman","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.018_bib35","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood.V99.4.1174","article-title":"Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro","volume":"99","author":"Filippi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib37","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1073\/pnas.92.12.5292","article-title":"Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation","volume":"92","author":"Gurney","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.018_bib38","first-page":"97a","article-title":"Hypersensitivity of polycythemia vera megakaryoctic progenitors to thrombopoetin","volume":"88","author":"Martin","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor","volume":"80","author":"Dai","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.018_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","article-title":"Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3","volume":"87","author":"Dai","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2007.09.018_bib41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","article-title":"Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor","volume":"379","author":"Meydan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2007.09.018_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2007.09.018_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.leu.2403700","article-title":"PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia","volume":"19","author":"Passamonti","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.09.018_bib44","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1073\/pnas.90.23.11351","article-title":"Erythropoietin receptor signals both proliferation and erythroid-specific differentiation","volume":"90","author":"Liboi","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.018_bib45","doi-asserted-by":"crossref","first-page":"P727","DOI":"10.1016\/S0092-8674(85)80053-2","article-title":"Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo","volume":"41","author":"Palacios","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2007.09.018_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/meth.1998.0734","article-title":"Thrombopoietin signal transduction: studies from cell lines and primary cells","volume":"17","author":"Drachman","year":"1999","journal-title":"Methods"},{"issue":"32","key":"10.1016\/j.leukres.2007.09.018_bib47","doi-asserted-by":"crossref","first-page":"23603","DOI":"10.1074\/jbc.M701120200","article-title":"The neutrophil specific antigen CD177 is a counter-receptor for endothelial PECAM-1 (CD31)","volume":"282","author":"Sachs","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.09.018_bib48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbamcr.2006.08.008","article-title":"Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine\/growth factor responses","volume":"1763","author":"Rege","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.leukres.2007.09.018_bib49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.ATV.19.2.290","article-title":"Urokinase activates the Jak\/Stat signal transduction pathway in human vascular endothelial cells","volume":"19","author":"Dumler","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.leukres.2007.09.018_bib50","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.onc.1204349","article-title":"Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells","volume":"20","author":"Garcia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.09.018_bib51","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M502750200","article-title":"Arginine-vasopressin activates the JAK-STAT pathway in vascular smooth muscle cells","volume":"281","author":"Levy","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.09.018_bib52","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1210092","article-title":"Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway","volume":"26","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.09.018_bib53","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/sj.onc.1203594","article-title":"IL-3 signaling and the role of Src kinases JAKs and STATs: a covert liaison unveiled","volume":"19","author":"Reddy","year":"2000","journal-title":"Oncogene"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T21:53:47Z","timestamp":1588024427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0145212607003578"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.09.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}